Poster # 1001 Use of Protoporphyrin Fluorescence to Determine Clinical Target Volume Margins for Non-Melanotic Skin Cancers Treated with Primary Radiotherapy

Presenter: Lara Best, MD




Click on images to enlarge (a new pop-up window will open)